WYMM Tour: Zurich
Tuesday 22nd October 2024, 10:00 - 16:45 CET - Zurich, Switzerland (timings subject to change)
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Tuesday 22nd October 2024 to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda below.
Agenda
10:00 — 17:00 | Agenda (subject to change) | Speaker |
|---|---|---|
10:00 — 10:45 | Registration and breakfast | |
10:45 — 11:10 | Welcome | Daniel Mathow, Oxford Nanopore Technologies |
11:10 — 11:35 | Evaluating the Diagnostic Potential of Long Reads for Rare Diseases | Stephan Ossowski, University of Tübingen |
11:35 — 12:00 | Real-time genomics for rapid antibiotic resistance prediction | Lara Urban, Helmholtz Munich |
12:00 — 13:30 | Lunch | |
13:30 — 13:55 | Bioinformatics update | Phill James, Oxford Nanopore Technologies |
13:55 — 14:20 | Whole genome long-read sequencing in SV calling and variant phasing | Janine Meienberg, Center for Cardiovascular Genetics and Gene Diagnostics of the Swiss Foundation for People with Rare Diseases, Switzerland |
14:20 — 14:45 | Single-molecule identification of m6A and pseudouridine sites in the diseased mouse heart by direct RNA-sequencing | Isabel Naarmann-de Vries, University Hospital Heidelberg, Germany |
14:45 — 15:00 | Application of Oxford Nanopore Technologies in Contract Research Organisations | Sergey Yakushev, Microsynth, Switzerland |
15:00 — 15:45 | Networking session | |
15:45— 16:15 | Panel Q&A session | Moderated by Cerissa French, Oxford Nanopore Technologies |
16:15 — 16:50 | Genetic and epigenetic profiling of repeat expansion and contraction disorders using nanopore sequencing | Morghan Lucas, MGZ Munich, Germany |
16:50 — 17:00 | Closing remarks | Oxford Nanopore Technologies |
17:00 — 20:00 | Drinks reception and networking |
Speakers
)
Welcome
Daniel Mathow, Sales Director EMEAI-Central, Oxford Nanopore Technologies
Phd and Postdoc in Molecular Biology and Genetics at DKFZ Heidelberg/Germany. 10 years commercial ex...
)
Evaluating the Diagnostic Potential of Long Reads for Rare Diseases
Stephan Ossowski, Professor for Genome Informatics, University of Tübingen
Stephan Ossowski is professor for Genome Informatics at the University of Tübingen and vice director...
)
Real-time genomics for rapid antibiotic resistance prediction
Lara Urban, Helmholtz Munich
Lara obtained her PhD in statistical genomics from EMBL-EBI, EMBL, and the University of Cambridge, ...
Phill James, Director, Genomic Applications, Oxford Nanopore Technologies
After his Ph.D. Phill undertook a wider range of research projects in academia focusing on the role ...
)
Whole genome long-read sequencing in SV calling and variant phasing
Janine Meienberg, Center for Cardiovascular Genetics and Gene Diagnostics of the Swiss Foundation for People with Rare Diseases, Switzerland
Janine Meienberg studied biology at the University of Zurich and conducted her PhD studies focusing ...
)
Single-molecule identification of m6A and pseudouridine sites in the diseased mouse heart by direct RNA-sequencing
Isabel Naarmann-de Vries, University Hospital Heidelberg, Germany
I studied Biochemistry at the Martin-Luther-University Halle-Wittenberg and then did my PhD in Halle...
)
Application of Oxford Nanopore Technologies in Contract Research Organisations
Sergey Yakushev, Microsynth, Switzerland
Sergey Yakushev studied protein biochemistry and molecular biology at Moscow State University and Un...
)
Panel moderator
Cerissa French, Oxford Nanopore Technologies
...
)
Genetic and epigenetic profiling of repeat expansion and contraction disorders using nanopore sequencing
Morghan Lucas, Co-lead of R&D, MGZ Munich, Germany
Morghan Lucas is the co-lead of R&D at the Medical Genetics Centre (MGZ) Munich and a visiting scien...